• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455; PubMed=25538140).
  
• Mutation; HGNC; HGNC:1424; CAD; Simple; p.Arg1854Gln (c.5561G>A); ClinVar=VCV001481207; Zygosity=Heterozygous (PubMed=27350335).
  
• Mutation; HGNC; HGNC:3330; EML1; Simple; p.Arg64Trp (c.190C>T); Zygosity=Heterozygous (PubMed=27350335).
  
• Mutation; HGNC; HGNC:8761; PDCD10; Simple; p.Pro28Ser (c.82C>T); Zygosity=Homozygous (PubMed=27350335).
  
• Mutation; HGNC; HGNC:30400; SEMA3G; Simple; p.Arg300Cys (c.898C>T); Zygosity=Heterozygous (PubMed=27350335).
  

PubMed=23685455; DOI=10.1038/nature12154
Kaplon J., Zheng L., Meissl K., Chaneton B., Selivanov V.A., Mackay G., van der Burg S.H., Verdegaal E.M.E., Cascante M., Shlomi T., Gottlieb E., Peeper D.S.
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
Nature 498:109-112(2013)

PubMed=25538140; DOI=10.15252/msb.20145450; PMCID=PMC4300494
Smit M.A., Maddalo G., Greig K., Raaijmakers L.M., Possik P.A., van Breukelen B., Cappadona S., Heck A.J.R., Altelaar A.F.M., Peeper D.S.
ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma.
Mol. Syst. Biol. 10:772-772(2014)

PubMed=27350335; DOI=10.1038/nature18945
Verdegaal E.M.E., de Miranda N.F.C.C., Visser M., Harryvan T., van Buuren M.M., Andersen R.S., Hadrup S.R., van der Minne C.E., Schotte R., Spits H., Haanen J.B.A.G., Kapiteijn E.H.W., Schumacher T.N., van der Burg S.H.
Neoantigen landscape dynamics during human melanoma-T cell interactions.
Nature 536:91-95(2016)